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ABSTRACT 
 
Background 
The administration of oral medication to patients with an enteral feeding tube (EFT) is challenging. 
Compliance to guidelines concerning medication administration via EFT has been investigated 
extensively  in the hospital setting. However, studies in residential care facilities (RCFs) for individuals 
with intellectual disability (ID) are very limited. Therefore, the present study aimed to collect direct 
observational data on drug administration practices to residents with EFT in multiple RCFs. 
Method 
This cross-sectional, observational study was conducted in six Belgian RCFs for individuals with ID. 
Observations of medication preparation and administration through EFT were carried out in two 
randomly selected units per participating RCF, on two days per unit during all daytime drug rounds, 
using a direct observation method. Afterwards, the recorded observations were compared with 
international guidelines on drug preparation and administration through EFT. 
Results 
In total, 862 drug preparations and 268 administrations in 48 residents with EFT were witnessed. 
Mixing together multiple drugs, not diluting liquid formulations with at least an equal amount of 
water, not shaking suspensions/emulsions before use, and not selecting the most appropriate dosage 
form were the most common deviations from medication preparation guideline recommendations. 
For medication administration, not flushing the EFT with at least 15mL water was the most common 
deviation. We also observed high variability in working methods regarding medication preparation 
and administration via EFT, even between staff members of the same unit. 
Conclusion 
This study found that current guidelines concerning medication preparation and administration 
through EFT are often not followed in Belgian RCFs for individuals with ID. Further research aimed at 
understanding why current guidelines are not followed seems warranted. 
 INTRODUCTION 
Feeding problems are highly prevalent in people with intellectual disabilities (ID). Severe/profound ID 
is often associated with problems regarding feeding skills (e.g. motor coordination and muscle tone) 
and with an increased aspiration risk (Gal et al. 2011). Therefore, this population often depends on 
an enteral feeding tube (EFT) for both feeding and the administration of drugs (Gal et al. 2011;White 
and Bradnam 2007). The administration of oral medication through the feeding tube is however 
challenging and may present some pitfalls. Firstly, when no appropriate liquid dosage form is 
available, solid dosage forms are often crushed and suspended in an amount of water to enable drug 
administration through the EFT (Bankhead et al. 2009;Williams 2008). However, not all oral solid 
dosage forms are suitable for crushing. In case of sustained release formulations (when administered 
through gastrostomy as well as jejunostomy), crushing leads to an immediate release of the total 
drug dose, which is higher than the total drug dose in regular immediate release formulations 
(Bankhead et al. 2009;White & Bradnam 2007). This may cause drug toxicity, as was demonstrated 
by a case in which a crushed sustained release nifedipine tablet led to a patient fatality (Schier et al. 
2003). In case of enteric coated formulations (when administered through gastrostomy), crushing 
may result in loss of drug efficacy or irritation of the gastric mucosa (depending on the reason for 
enteric coating) (White & Bradnam 2007). Secondly, inappropriate drug formulations may cause tube 
obstructions; e.g. the administration of bulk-forming laxatives or inadequately crushed tablets, or the 
administration of a “cocktail” of several oral dosage forms, possibly together with feeding, is 
associated with an increased risk for tube clogging (White & Bradnam 2007;Williams 2008). Thirdly, 
concurrent administration of oral medication and enteral feeding may lead to drug-nutrient 
interactions; e.g. concurrent administration of enteral feed and phenytoin leading to a reduced 
phenytoin absorption and therapeutic effect (Boullata and Hudson 2012;Lourenco 2001;White & 
Bradnam 2007;Wohlt et al. 2009). Similarly, mixing together multiple drugs for administration 
through EFT may result in physicochemical incompatibilities (Bankhead, Boullata, Brantley, Corkins, 
Guenter, Krenitsky, Lyman, Metheny, Mueller, Robbins, & Wessel 2009;White & Bradnam 2007). 
These unwanted and often unforeseen risks with drug administration through the EFT, can lead to 
patient harm or even death (Schier et al. 2003). Besides, administering a drug via an EFT usually falls 
outside the terms of the drug’s product license, resulting in the prescriber, dispenser and 
administrator becoming liable for any harm that occurs from taking the medication (White & 
Bradnam 2007). 
To reduce these risks, guidelines for the administration of medication through EFT have been issued. 
These include careful selection and preparation of appropriate dosage forms, withholding feeding 
during drug administration, separate administration of drug doses and adequate flushing of the EFT 
(Bankhead et al. 2009;White & Bradnam 2007). However, research investigating whether these 
special precautions are actually followed in residential care facilities (RCFs) for individuals with ID is 
limited to two studies from the Netherlands. Van den Bemt et al. studied the frequency of drug 
administration errors in one RCF for residents with ID (with and without EFT) (van den Bemt et al. 
2007). They found that errors were common and that drug administration via EFT was a determinant 
associated with errors (odds ratio 189.66; 95% confidence interval). In a follow-up study, the same 
authors evaluated the effect of an intervention program designed to reduce errors when 
administering medication through EFT (Idzinga et al. 2009). This program showed to be effective, 
although the proportion of administration errors after the intervention was still considered high (in 
particular the  EFT related preparation errors). In the hospital setting, compliance to guidelines 
concerning drug administration via EFT has been studied more extensively (Bertsche et al. 2010;Ech-
chaouy et al. 2007;Heydrich et al. 2009;Kelly et al. 2011;Lonergan et al. 2010;Triki et al. 2012;van den 
Bemt et al. 2006). These studies all observed deviations from guidelines to a certain extent (e.g. 
mixing several drugs together, crushing of modified-release formulations, not flushing EFTs,…) (Ech-
chaouy et al. 2009;Kelly et al. 2011;Triki et al. 2012;van den Bemt et al. 2006). Moreover, a recent 
study investigating the role of the clinical pharmacist in improving medication administration through 
EFT, found that most nurses did not have sufficient knowledge about rules of drug administration via 
EFT (Dashti-Khavidaki et al. 2012). In RCFs for people with ID, medication is mainly administered by 
non-medically trained staff (e.g. educators) (Joos et al. 2013), which may lead to even more errors. In 
addition, residents with ID are especially at risk for medication errors due to their high medication 
use (Idzinga et al. 2009) and the fact that they may not be aware of errors because of their cognitive 
impairment (van den Bemt et al. 2007). 
Therefore, the present study aimed to collect direct observational data on drug administration 
practices to patients with EFT in several RCFs for people with ID. 
 METHODS 
STUDY DESIGN AND SETTING 
This cross-sectional, observational study was conducted from March to June 2012 in RCFs for 
individuals with an ID in Belgium. We approached six randomly selected RCFs with at least 10 
residents with EFT. All six agreed to participate. The RCFs included in this study are relatively large 
campus-style accommodations. They offer (semi-) residential care to people with mild to profound ID 
(often associated with other disabilities), who cannot be cared for at home. These RCFs provide 
medical, pedagogic, psychological and social services, and are often linked to special schools. 
Approval for the study was granted by the local Ethical Committee. All directors of the RCFs and the 
observed staff members gave written informed consent. For the observed residents we used an opt-
out arrangement (i.e. residents’ parents or guardian were offered the opportunity to opt-out of study 
participation by signing an opt-out form) (Junghans et al. 2005;Vellinga et al. 2011). 
DATA COLLECTION 
Observations of medication administration through EFT were carried out in two randomly selected 
units of the participating RCFs. A unit is a living group of approximately 10 residents, where daily care 
and support is provided by educators and/or caretakers and/or nurses. A direct observation method 
(Allan and Barker 1990;Barker et al. 2002) was used with two observers witnessing preparation and 
administration of drugs through EFT on two random days per unit, during all daytime drug rounds 
(from 6 am to 9 pm). The observers wrote down exactly what the nurses did during the preparation 
and administration of medication. Data recorded included resident codes, drug product, dosage 
form, amount of drug, and all procedures related to medication preparation (e.g. tablet crushing) and 
administration (e.g. stopping enteral feeding). Afterwards, the recorded observations were 
compared with international guidelines on drug preparation and administration through EFT 
(Bankhead et al. 2009;Boullata 2009;British Association for Parenteral and Enteral Nutrition 
2013;White & Bradnam 2007). An expert panel of three pharmacists (E.J., E.M., K.B.) selected the 
A.S.P.E.N. guidelines (Bankhead et al. 2009;Boullata 2009), and the Handbook of Drug Administration 
via Enteral Feeding Tubes by (White & Bradnam 2007) as guideline standards. As these guidelines do 
not provide a concrete advice concerning the dilution of medication before administration through 
the EFT, a literature review on this topic was undertaken that identified several extra 
recommendations (American Society of Consultant Pharmacists 2013;British Association for 
Parenteral and Enteral Nutrition 2013;Wohlt et al. 2009). All recommendations agree on the 
necessity of diluting (American Society of Consultant Pharmacists 2013;Bankhead et al. 2009;Boullata 
2009;British Association for Parenteral and Enteral Nutrition 2013;White & Bradnam 2007;Wohlt et 
al. 2009), but there seems to be inconsistency regarding the amount of liquid used. For liquid 
medication, the recommendations vary from ‘dilute as appropriate’ (Bankhead et al. 2009;Boullata 
2009), over ‘dilute with an equal amount’ (British Association for Parenteral and Enteral Nutrition 
2013), or ‘with 10-30mL’ (American Society of Consultant Pharmacists 2013), to ‘dilute with at least 
with 30mL’ (Wohlt et al. 2009). Therefore, the expert panel decided to select the minimal, concrete 
advice available in these guidelines as guideline standard, i.e. ‘dilute with an equal amount’. For 
dilution of solid medication, ‘dilute with at least 10mL’ was chosen as the minimal, concrete advice. 
The guidelines for respectively medication preparation and medication administration are detailed in 
Table 1 and 2 (first column). In addition, the following resident characteristics were collected: age, 
sex, weight, severity of ID, type and size of EFT, and type of enteral feeding regimen. 
DATA ANALYSIS 
Descriptive data analysis was performed using Microsoft Excel 2010. All data were processed 
anonymously. 
 
RESULTS 
The parents of one resident opted out of study participation. A total of 11 nurses and 28 
educators/caretakers were observed during the study period. Altogether 862 drug preparations and 
268 administrations (one administration is defined as one administration moment to one resident, 
independent of the number of drugs administered at that moment) in 48 residents with EFT were 
witnessed. Resident characteristics are displayed in Table 3. Residents received multiple medications 
via EFT, with a median of six per resident (range 1-14). We also noticed that there were differences in 
working methods during medication preparation and administration, not only between the RCFs, but 
also between units in the same RCF, and sometimes even within the same unit. 
Medication preparation 
About 55% of the prepared drugs (470/862) were solid dosage forms (Table 4), with 1.7% (15/862) 
being non-crushable (i.e. sustained release formulations for administration through gastrostomy as 
well as jejunostomy, and enteric coated formulations for administration through gastrostomy). These 
formulations included sustained release formulations of valproic acid (n=4) and carbamazepine (n=3), 
and enteric coated formulations of omeprazole (n=4), esomeprazole (n=2) and pantoprazole (n=2). 
Valproic acid (121/862), baclofen (70/862) and levetiracetam (58/862) were the three  most 
frequently prepared drugs (Table 5). 
Table 1 summarizes all recommendations found in literature relating to medication preparation 
procedures, as well as the frequency of their relevance and their implementation in our 
observations. Mixing together multiple drugs was the most common deviation from guidelines. 
About two thirds (69%, 599/862) of the prepared drugs were mixed together before administration, 
which generated 165 cocktails. These cocktails were combinations of 2 drugs (53/165, 32%), 3 drugs 
(47/165, 28%), 4 drugs (19/165, 12%), or ≥5 drugs (46/165, 28%; max. 8 drugs). Other frequently 
observed deviations from guidelines were: not diluting liquid formulations with at least an equal 
amount of water, crushing different tablets together, not shaking suspensions/emulsions before use, 
and not selecting the most appropriate dosage form. Only about half (210/392, 54%) of the liquid 
dosage forms were diluted with at least an equal amount of water, whereas forty-five per cent 
(177/392) of them were not diluted at all. A total of 155 drugs was crushed. We observed 
considerable variability in crushing methods: in 64% conventional crushing devices were used 
(commercial pill crusher (63/155) or pestle and mortar (36/155)), while in 36% non-conventional 
devices were used (pestle and metal cup (42/155), or two metal cups (14/155)). We noticed that 
crushing devices were often shared and not cleaned between drug preparations for different 
residents. Hence, cross-contamination was possible in 45 of 268 (17%) medication administrations. In 
all residents, at least one deviation from medication preparation guidelines was observed. 
Drugs were prepared ≤15 min (499/862), 16-30 min (132/862), 31-60 min (58/862), and > 60 min 
(170/862) before administration to the resident (max. 21h). In three cases (3/862), the time span 
between preparation and administration could not be determined as the prepared drug was not 
administered (resident went home or was too nauseated). 
Medication administration 
Table 2 summarizes all recommendations found in literature relating to medication administration 
procedures, as well as the frequency of their relevance and their implementation in our 
observations. When comparing our observations of medication administration with guidelines, we 
found that not flushing the EFT with at least 15mL water before and after drug administration, not 
using a syringe of ≥ 30 mL in size for drug administration, not elevating the resident’s backrest ≥ 30°, 
and not rinsing the medicine cup were the most common deviations. For most observations flushing 
between drug administrations was not applicable since all drugs administered at one administration 
moment were mixed together as a cocktail. The guideline stating that the EFT needs to be flushed 
with at least 15mL water before, between and after medication administration, was not followed in 
most cases;  respectively in 98.9% (265/268), 98.8% (82/83), and 33.6% (90/268) of administrations. 
However, it is relevant to note that in some of these cases, the EFT was flushed with less than 15mL 
water before, between or after medication administration; respectively in 3.7% (10/268), 14.5% 
(12/83), and 10.4% (28/268) of the observations. We also noticed that in one RCF, EFTs were 
consistently flushed with cola. In all residents, at least one deviation from medication administration 
guidelines was observed. 
DISCUSSION 
Main findings 
This cross-sectional observational study found that current guidelines concerning medication 
preparation and administration through EFT are often not followed in Belgian RCFs for individuals 
with ID. 
Regarding medication preparation, mixing together two or more drugs was the most frequent 
deviation from guidelines (observed in about 2/3 of prepared medication). Whether mixing together 
different medications actually results in physicochemical incompatibilities should be studied 
experimentally case-by-case as this depends on various factors (i.e. the physicochemical properties 
of the active ingredients as well as the excipients). Incompatibility is thus difficult to predict 
(Bankhead et al. 2009), and therefore guidelines recommend to avoid mixing medications. The 
second most frequent deviation from guidelines was not diluting liquid medication (observed in 
about half of liquid medication), which is recommended to reduce viscosity, and, consequently, the 
resistance to flow through an EFT (Bankhead et al. 2009;Boullata 2009). For example for liquid 
dosage forms of carbamazepine and phenytoin, it has been shown that dilution prior to 
administration is associated with improved delivery of the drug dose to the distal end of the tube 
(Clark-Schmidt et al. 1990;Seifert et al. 1993). Another common deviation from guidelines was not 
shaking suspensions/emulsions before use (observed in about half of prepared 
suspensions/emulsions). This leads to a high variability in the doses administered, and consequently 
to underdosing and therapeutic failure on one occasion, and overdosing and potential toxicity on 
another (GrieBmann et al. 2007). This was demonstrated by an experimental study of the 
consequences of not shaking an amoxicillin suspension, which revealed manifest dosing errors (e.g. 
doses <10% of the labeled content) (GrieBmann et al. 2007). In our sample, the unshaken 
suspensions contained the antibiotics azithromycin, ciprofloxacin, trimethoprim-sulfamethoxazole 
and the antiepileptic drug carbamazepine. It seems likely that not shaking these formulations will 
have clinical consequences for the patient. Additionally, although not occurring frequently, we 
observed crushing of modified-release dosage forms (i.e. sustained release formulations for 
administration through gastrostomy as well as jejunostomy, and enteric coated formulations for 
administration through gastrostomy). In our sample, crushed sustained release formulations 
contained valproic acid and carbamazepine. Crushed enteric coated formulations contained proton 
pump inhibitors (PPI) (es)omeprazole and pantoprazole. PPIs are known to be very acid labile 
molecules, e.g. the degradation half-life of omeprazole is <2 minutes at pH2 (Pilbrant 2013). 
Treatment failure due to crushing omeprazole has been reported (Cornish 2005). 
Regarding medication administration, not flushing the EFT with at least 15mL water (before, 
between and after medication administration) was a frequent deviation from guidelines. Flushing of 
the EFT is recommended in order to prevent tube blockage, to avoid possible physicochemical 
interactions, and to prolong the life of the EFT (Bankhead et al. 2009). One RCF in our sample 
consistently flushed with cola instead of water (the preferred flushing solution (Bankhead et al. 
2009;Dandeles and Lodolce 2011;White & Bradnam 2007)). Cola is an acidic fluid and can cause or 
exacerbate EFT occlusions by causing feed to coagulate or protein to denature (White & Bradnam 
2007). 
Notwithstanding guidelines are often not followed, also good practice was observed. During drug 
preparation, in the majority of the observations solid medication was diluted with at least 10mL 
water, the most suitable drug formulation was chosen, and hard gelatin capsules were opened and 
contents were mixed with water. Regarding medication administration, medication was never added 
directly to an enteral feeding formula, and tubes were mostly flushed with the preferred flushing 
solution water. 
Another important finding is the high variability in working methods regarding medication 
preparation and administration via EFT, even between staff members of the same unit. This is 
consonant with our previous study on the entire medication management process, where a large 
variation in procedures was identified between the participating RCFs (n=34), and even between 
units within the same RCF (Joos et al. 2013). 
Comparison with literature and possible strategies to improve guideline adherence 
To the best of our knowledge, only the study of Idzinga et al. focused on medication administration 
through EFT in an RCF for individuals with ID. They described that preparation errors occurred in 
37% of (baseline) observations, and also identified not flushing the EFT as the main administration 
error, although this deviation occurred less frequently than in our observations (in respectively 2%, 
11%, and 1% of observations, EFTs were flushed before, between and after medication 
administration) (Idzinga et al. 2009). Idzinga et al. also evaluated an intervention program that 
addressed these issues, and included communicating to the pharmacist which clients have EFT, 
advice on medication administration via EFT by the pharmacist, a ‘medication through tube’ box, and 
training sessions. This program was found to be effective, although the proportion of administration 
errors after the intervention was still considered high. 
The results of our study are also in line with previous research in the hospital setting (Ech-chaouy et 
al. 2007;Heydrich et al. 2009;Seifert et al. 2002;Triki et al. 2012;van den Bemt et al. 2006), where 
mixing together medications, crushing of sustained release formulations, and not flushing the EFT 
were reported. Reported percentages of mixing together medications range from 38% to 98% of the 
observations (Ech-chaouy et al. 2007;Triki et al. 2012;van den Bemt et al. 2006), whereas crushing of 
sustained release formulations for administration through the EFT ranges from 3% to 5% of the 
observations (Ech-chaouy et al. 2007;Triki et al. 2012). Concerning the issue of flushing the EFT, 
mainly flushing before (not flushed in 11%-100% of observations (Ech-chaouy et al. 2007;Triki et al. 
2012;van den Bemt et al. 2006) and between (not flushed in 100% of observations (Ech-chaouy et al. 
2007;Triki et al. 2012)) drug administrations was not performed in the hospital setting (Ech-chaouy et 
al. 2007;Heydrich et al. 2009;Triki et al. 2012;van den Bemt et al. 2006). Intervention programs in this 
setting have shown to be effective in improving medication administration through EFT. The 
intervention in the study of van den Bemt et al. (van den Bemt et al. 2006) consisted of daily ward 
visits by pharmacy technicians, introducing working instructions, and “enteral feeding tube” and “do 
not crush” indications. It resulted in a decrease in the number of tube obstructions and to a 
significant decrease in the number of administration errors per nurse. Dashti-Khavidaki et al. (Dashti-
Khavidaki et al. 2012) found that an integrated educational program (i.a. booklet on administration 
technique/dosage forms, training session, and detailed working instruction) significantly improved 
knowledge and practice of nurses. Medication errors in the intervention group decreased from 43 % 
pre-intervention to 27 % post-intervention. 
Strengths and limitations 
To our knowledge, this is the first study describing in detail medication administration via EFT in 
multiple RCFs. However, our study also had some limitations. Main limitation is that we did not 
assess whether the observed guideline deviations actually caused patient harm, such as patient 
morbidity and/or mortality. However, in view of the relatively low incidence of these effects, a much 
larger sample size would be needed, which was beyond the scope of our study. Another limitation is 
the concern about the unexpected and unexplained reactivity to the observations of the staff 
members who are aware of their participation in a study, also known as the Hawthorne effect (Adair 
1984). However, concern that observers would make the observed staff member more careful 
(preventing errors and thus underestimating deviations) or more nervous (leading to more mistakes) 
seems unfounded when they are doing an activity familiar to them (Allan & Barker 1990;Dean and 
Barber 2001). Finally, because of the time consuming nature of the observation method, 
observations were limited to two workdays (from 6 am to 9 pm), and drug administrations at 
nighttime or during the weekend were not observed. As staffing is lower during weekends and 
nights, frequency of guideline deviations may therefore even be underestimated. 
Implications for practice and future research 
Our observations demonstrate the need for practical, unequivocal recommendations and education 
programs on the administration of drugs via EFT in this setting. For example, the inappropriate 
crushing in our study may have been avoided if the delivering pharmacist had known which residents 
receive their medication through EFT, combined with the development and implementation of clear 
and practical local guidelines in each RCF, and training sessions for staff members. This type of 
training could reduce inappropriate crushing, as already demonstrated in an intervention study in 
nursing homes (Verrue et al. 2010). However, before implementing an intervention program, further 
research is needed to better understand why current guidelines are not followed by staff members 
of RCFs for individuals with ID. According to Idzinga et al., the small effect of the intervention on the 
EFT related preparation errors could partly be explained by the lack of information provided by the 
pharmacy (only part of the medication on the administration record was accompanied by a pharmacy 
advice on the correct mode of administration), and partly by the nurse attendants not following up 
on the pharmacy advices (Idzinga et al. 2009). In order to know exactly what the reasons are for not 
following guidelines, qualitative research in this area is needed. Based on this knowledge, an 
appropriate intervention with unequivocal, practicable guidelines can be set up and implemented in 
order to improve medication administration through EFT in individuals with ID. 
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Tables & figures 
 
Table 1  Medication preparation: recommendations found in literature, and the frequency of their 
relevance and implementation in our sample of 862 observed drug preparations 
Guideline 
Guideline 
relevant 
Observations NOT compliant 
with guideline 
Top 3 drugs involved in non-
compliance (n) 
 
 n n %*   
Avoid mixing together medications a,b 862 599 69,5% N.a.** 
Dilute liquid medication with at least an equal 
amount of water d 
392 182 46,4% 
Valproic acid (38), 
levetiracetam (28), 
omeprazole (23) 
Do not crush tablets together c 155 130 83,9% N.a.** 
Shake suspensions/emulsions thoroughly 
before use a,b 
127 65 51,2% 
Alginic acid (25), 
domperidone (11), 
omeprazole (11) 
Select most suitable formulationⱡ a,b 862 58 6,7% 
Levetiracetam (9), 
carbamazepine (7), 
levodopa/benserazide (6) and 
lorazepam (6) 
Dilute solid medication with at least 10mL of 
water d 
470 29 6,2% 
Baclofen (9),  
topiramate (5),  
phenobarbital (3) 
Open hard gelatin capsules (if allowed) and 
mix contents with water a,b 
134 28 20,9% 
Phenobarbital (13),  
baclofen (10),  
glycopyrronium bromide (2) 
and nitrofurantoin (2) 
Do not crush sustained release dosage forms 
a,b 
7 7 100,0% 
Valproic acid (4), 
carbamazepine (3) 
Do not crush enteric coated dosage forms in 
case of gastrostomy a,b 
8 6 75,0% 
Esomeprazole (2),  
omeprazole (2),  
pantoprazole (2) 
Use protective equipment when crushing 
drugs like hormones or antibiotics b 
6 6 100,0% Levothyroxine sodium (6) 
*
 Percentage calculated on nrelevant 
    ** Not applicable 
    
ⱡ If available, use liquids or dissolvable/dispersible tablets 
   a
 (Bankhead, Boullata, Brantley, Corkins, Guenter, Krenitsky, Lyman, Metheny, Mueller, 
Robbins, & Wessel 2009))   
b
 (White & Bradnam 2007)    
c 
(Boullata 2009) 
    
d
 (British Association for Parenteral and Enteral 
Nutrition 2013) 
    
  
Table 2   Medication administration: recommendations found in literature, and the frequency of their 
relevance and implementation in our sample of 268 observed drug administrations 
 
Guideline Guideline relevant 
Observations NOT 
compliant with guideline 
 
 n n %* 
Before medication administration, flush with at 
least 15mL water a,b 
268 265 98.9% 
Administer using a syringe ≥30mL in size a 268 165 61.6% 
Elevate the backrest to a minimum of 30° a,b 268 130 48.5% 
If used, ensure that the medicine cup is rinsed 
with water b 
243 130 53.5% 
After medication administration, flush with at 
least 15mL water a,b 
268 90 33.6% 
Between drugs, flush with at least 15mL water a,b 83 82 98.8% 
Preferred flush solution is water a,b 246 44 17.9% 
Temporarily hold administration of the enteral 
nutrition formula during medication 
administration a,b 
106 37 34.9% 
Hold the feeding by 30min or more when 
separation is indicated a 
4 4 100.0% 
Do not add medication directly to an enteral 
feeding formula a,b 
268 0 0.0% 
*
 Percentage calculated on nrelevant 
   
a
 (Bankhead, Boullata, Brantley, Corkins, Guenter, Krenitsky, Lyman, Metheny, Mueller, Robbins, & 
Wessel 2009) 
 b (White & Bradnam 2007) 
  
Table 3  Resident characteristics 
Resident characteristics n=48 
Age (years), median (range) 15.0 (3-62) 
Male sex 22 
Weight (kg), mean (SD) 34.7 (13.5) 
Grade of ID 
 
 
Severe (IQ 20-39) 2 
 
Profound (IQ<20) 46 
Tube type 
 
 
Gastrostomy 47 
 
Jejunostomy 1 
Tube size 
 
 
10 French 4 
 
14 French 22 
 
15 French 4 
 
16 French 5 
 
18 French 5 
 
Size unknown 8 
Type of feeding regimen 
 
 
Continuous 0 
 
Cyclic 6 
 
Intermittent 34 
 
Bolus 4 
 
No enteral feeding 4 
Number of drugs via EFT per 
resident, median (range) 
6.0 (1-14) 
Number of administration 
moments per day 
 
 1 
1 
 2 
3 
 3 
25 
 4 
12 
 5 
2 
 6 
4 
  7 1 
Data are presented as n, unless indicated otherwise. 
 
 
Table 4  Galenic form of the prepared medications (n=862) 
        n (%) 
so
lid
 
Tablets 295 (34.2) 
 
Non-dispersible 
  
  
crushable 211 (24.5) 
  
non-crushable 
* 
15 (1.7) 
 
Dispersible 69 (8.0) 
Capsules 134 (15.5) 
 
Openable 134 (15.5) 
 
Non-openable 0 (0.0) 
Powder/granules 41 (4.8) 
liq
u
id
 Solutions 265 (30.7) 
Suspensions 124 (14.4) 
Emulsions 3 (0.3) 
 * i.e. sustained release formulations in all cases, and enteric coated formulations for administration through gastrostomy 
  
Table 5  Top 10  most frequently prepared drugs (n=862) 
ATC Code Drug name n (%) 
N03AG01 Valproic acid 121 (14.0) 
M03BX01 Baclofen 70 (8.1) 
N03AX14 Levetiracetam 58 (6.7) 
N03AX09 Lamotrigine 48 (5.6) 
A02BC01 Omeprazole 47 (5.5) 
N03AE01 Clonazepam 28 (3.2) 
A02BX13 Alginic acid 27 (3.1) 
A03FA03 Domperidone 26 (3.0) 
N03AA02 Phenobarbital 25 (2.9) 
N05BA09 Clobazam 23 (2.7) 
  
 
 
